Department of Pathology, Wakayama Medical University School of Medicine, Wakayama, Japan.
Department of Pathology, Wakayama Medical University School of Medicine, Wakayama, Japan.
Am J Pathol. 2021 Mar;191(3):555-566. doi: 10.1016/j.ajpath.2020.11.011. Epub 2020 Dec 8.
Keratin 17 (KRT17) expression promotes the proliferation and invasion of oral squamous cell carcinoma (OSCC), and mutations in TP53 have been reported in 65% to 85% of OSCC cases. We studied the correlation between KRT17 expression and TP53 mutants. Ca9-22 cells, which exhibit low KRT17 expression, carried mutant p53 (p53R248W) and p53R248W knockdown promoted KRT17 expression. p53R248W knockdown in Ca9-22 cells promoted migration and invasion activity. In contrast, in HSC3 cells, which have p53 nonsense mutations and exhibit high KRT17 expression, the overexpression of p53R248W decreased KRT17 expression, cell size, proliferation, and migration and invasion activities. In addition, p53R248W significantly suppressed MMP2 mRNA expression and enzyme activity. Moreover, s.c. and orthotopic xenografts were generated from p53R248W- or p53R248Q-expressing HSC3 cells. Tumors formed from p53R248W-expressing HSC3 cells grew more slowly and had a lower Ki-67 index than those derived from the control or p53R248Q-expressing HSC3 cells. Finally, the survival rate of the mice inoculated with p53R248W-expressing HSC3 cells was significantly higher than that of the control mice. These results indicate that the p53R248W mutant suppresses proliferation and invasion activity through the suppression of KRT17 expression. We propose that OSCC with p53R248W-expressing cells may be classified as a new OSCC type that has a good prognosis.
角蛋白 17(KRT17)的表达促进了口腔鳞状细胞癌(OSCC)的增殖和侵袭,据报道,TP53 的突变发生在 65%到 85%的 OSCC 病例中。我们研究了 KRT17 表达与 TP53 突变体之间的相关性。Ca9-22 细胞表达低水平的 KRT17,携带突变型 p53(p53R248W),并且 p53R248W 敲低促进了 KRT17 的表达。p53R248W 敲低在 Ca9-22 细胞中促进了迁移和侵袭活性。相比之下,在 HSC3 细胞中,p53 具有无义突变,并且表达高水平的 KRT17,过表达 p53R248W 降低了 KRT17 的表达、细胞大小、增殖以及迁移和侵袭活性。此外,p53R248W 显著抑制了 MMP2 mRNA 的表达和酶活性。此外,从表达 p53R248W 的 HSC3 细胞或 p53R248Q 的 HSC3 细胞生成了皮下和原位异种移植。与来自对照或 p53R248Q 表达的 HSC3 细胞的肿瘤相比,来自表达 p53R248W 的 HSC3 细胞的肿瘤生长更缓慢,Ki-67 指数更低。最后,接种表达 p53R248W 的 HSC3 细胞的小鼠的存活率明显高于对照组。这些结果表明,p53R248W 突变体通过抑制 KRT17 的表达抑制了增殖和侵袭活性。我们提出,具有 p53R248W 表达细胞的 OSCC 可能被归类为具有良好预后的新型 OSCC 类型。